ProPhase Labs, Inc

(NASDAQ:PRPH)

Latest On ProPhase Labs, Inc (PRPH):

Date/Time Type Description Signal Details
2023-05-11 23:45 ESTNewsProPhase Labs, Inc. (PRPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 09:32 ESTNewsProPhase Labs GAAP EPS of $0.03 beats by $0.13, revenue of $19.3M beats by $4.17MN/A
2023-05-10 19:40 ESTNewsProPhase Labs Q1 2023 Earnings PreviewN/A
2023-05-03 14:32 ESTNewsProPhase Labs' Linebacker-1 cancer therapeutic shows promising mechanisms of actionsN/A
2023-03-29 02:06 ESTNewsProPhase Labs, Inc. (PRPH) Q4 2022 Earnings Call TranscriptN/A
2023-03-28 10:40 ESTNewsProPhase Labs GAAP EPS of $1.02 misses by $0.10, revenue of $122.65M beats by $1.31MN/A
2023-03-27 19:32 ESTNewsProPhase Labs Q4 2022 Earnings PreviewN/A
2023-03-15 15:43 ESTNewsProPhase Labs launches $6M stock buyback planN/A
2023-03-02 20:48 ESTNewsProPhase Labs: Lots Of Moving PiecesN/A
2022-12-21 09:33 ESTNewsProPhase Labs: Betting On DNA Sequencing For Future Growth (Rating Downgrade)N/A
2022-11-10 22:04 ESTNewsProPhase Labs GAAP EPS of $0.06 misses by $0.13, revenue of $24.2M beats by $2.77MN/A
2022-11-10 22:03 ESTNewsProPhase Labs, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-10 22:03 ESTNewsProPhase Labs, Inc. (PRPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 04:43 ESTNewsProPhase Labs Q3 2022 Earnings PreviewN/A
2022-10-27 13:23 ESTNews3 Small-Cap Pharma Stocks For A 2023 Melt-UpN/A
2022-10-13 15:33 ESTNewsProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth PotentialN/A
2022-08-12 06:48 ESTNewsProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 14:21 ESTNewsProPhase Labs GAAP EPS of $0.40 beats by $0.24, revenue of $29.09M beats by $5.77MN/A
2022-08-10 22:19 ESTNewsProPhase Labs Q2 2022 Earnings PreviewN/A
2022-07-26 20:06 ESTNewsProPhase Labs announces $6M buyback planN/A
2022-07-26 06:41 ESTNewsProPhase Labs: A Growth Stock At An Attractive ValuationN/A
2022-07-22 21:28 ESTNewsDSS stock pops on licensing deal with ProPhase LabsN/A
2022-07-22 03:06 ESTNewsProPhase Labs to license two investigational cancer compounds from Global BioLifeN/A
2022-06-29 03:37 ESTNewsProPhase Labs forms new unit for licensing and development of drugs, compounds & biotechN/A
2022-05-24 05:51 ESTDividendA dividend of $0.3 has been announced on May 9, 2022. It will be paid Jun 3, 2022 with an ex-dividend date of May 24, 2022.Neutral
2022-05-16 17:48 ESTNewsProPhase Labs: A Stellar Quarter And Another Special DividendN/A
2022-05-14 02:17 ESTNewsProPhase Labs GAAP EPS of $0.81 beats by $0.34, revenue of $47.5M beats by $15.45MN/A
2022-05-14 02:17 ESTNewsProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 12:20 ESTNewsProPhase Labs names new finance chiefN/A
2022-03-30 22:49 ESTNewsProPhase Labs GAAP EPS of $0.68 beats by $0.11, revenue of $45.2M beats by $10.2MN/A
2022-03-30 22:48 ESTNewsProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 04:52 ESTDividendA dividend of $0.3 has been announced on Feb 14, 2022. It will be paid Mar 10, 2022 with an ex-dividend date of Feb 28, 2022.Neutral
2022-02-17 02:28 ESTNewsProPhase Labs declares $0.30 special dividendN/A
2022-01-13 19:52 ESTNewsProPhase Labs Q4 2021 COVID-19 testing volumes surpass previous levelsN/A
2021-11-24 04:11 ESTNewsProPhase Labs announces inducement grantN/A
2021-11-13 02:45 ESTNewsProPhase Labs EPS misses by $0.02, beats on revenueN/A
2021-11-13 02:44 ESTNewsProPhase Labs' (PRPH) CEO Ted Karkus on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-20 14:00 ESTNewsAs Employer Vaccine Mandates Fail, Prophase Labs Could BenefitN/A
2021-10-14 03:38 ESTNewsProPhase Labs expects sequential drop in COVID-19 testing revenues for Q3N/A
2021-09-08 14:29 ESTNewsProPhase Labs launches $6M share repurchase programN/A
2021-08-14 15:38 ESTNewsProPhase Labs' (PRPH) CEO Ted Karkus on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-13 19:23 ESTNewsProPhase Labs EPS misses by $0.26, misses on revenueN/A
2021-08-12 02:31 ESTNewsProPhase Labs acquires Nebula Genomics in $14.6M dealN/A
2021-07-21 20:26 ESTNewsProPhase Labs diversifies creating genomics and global healthcare subsidiariesN/A
2021-07-21 20:10 ESTNewsProPhase Labs joins the Russell Microcap IndexN/A
2021-07-21 20:09 ESTNewsProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 VariantsN/A
2021-05-24 05:52 ESTDividendA dividend of $0.3 has been announced on May 13, 2021. It will be paid Jun 3, 2021 with an ex-dividend date of May 24, 2021.Neutral
2021-04-01 02:42 ESTNewsProPhase Labs gains on VaccTrack acquisitionN/A
2021-04-01 02:42 ESTNewsProPhase Labs EPS misses by $0.08, misses on revenueN/A
2021-04-01 02:41 ESTNewsProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2020 Results - Earnings Call TranscriptN/A

About ProPhase Labs, Inc (PRPH):

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support product; and Super ProstaFlow+ a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; and offers COVID-19 and other respiratory pathogen panel testing services. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.

PRPH Quotes by TradingView

See Advanced Chart

General

  • Name ProPhase Labs, Inc
  • Symbol PRPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 48
  • Last Split Factor2:1
  • Last Split Date1997-01-23
  • Fiscal Year EndDecember
  • IPO Date1997-01-16
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.prophaselabs.com
View More

Valuation

  • Forward PE 3.74
  • Price/Sales (Trailing 12 Mt.) 7.11
  • Price/Book (Most Recent Quarter) 10.79
  • Enterprise Value Revenue 9.11
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin -13%
  • Operating Margin -14%
  • Return on Assets -6%
  • Return on Equity -14%
  • Revenue 12.49 million
  • Earnings Per Share -$0.33
  • Revenue Per Share $1.08
  • Gross Profit 2.62 million
  • Quarterly Earnings Growth 38.8%
View More

Highlights

  • Market Capitalization 109.26 million
  • EBITDA -3235000
  • Analyst Target Price $22.5
  • Book Value Per Share $0.93
View More

Share Statistics

  • Shares Outstanding 15.15 million
  • Shares Float 9.45 million
  • % Held by Insiders 2422%
  • % Held by Institutions 4.17%
  • Shares Short 74997
  • Shares Short Prior Month 99651
  • Short Ratio 0.38
  • Short % of Float 1%
View More

Technicals

  • Beta 0.01
  • 52 Week High $16.04
  • 52 Week Low $1.37
  • 50 Day Moving Average 8.84
  • 200 Day Moving Average 8.19
View More

Dividends

  • Forward Annual Dividend Yield 13.16%
  • Dividend Date 2019-12-12
  • ExDividend Date 2019-12-02
  • Dividend Yield 0%
View More

ProPhase Labs, Inc (PRPH) Dividend Calendar:

PRPH's last dividend payment was made to shareholders on December 12, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ProPhase Labs, Inc (PRPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-19$N/A-$0.04
2020-06-302020-09-30$N/A-$0.05
2020-03-312020-06-30$1.89 million$0.01
2019-12-312020-03-31$N/A-$0.07$0.00
2019-09-302019-11-12$2.77 million-$0.04
2019-06-302019-09-30$1.65 million-$0.04
2019-03-312019-06-30$2.32 million-$0.11
2018-12-312019-03-31$4.09 million-$0.09
2018-09-302018-12-31$2.44 million-$0.04
2018-06-302018-09-30$3.19 million-$0.08
2018-03-312018-06-30$3.41 million-$0.02
2017-12-312018-03-31$4.15 million$0.00
2017-09-302017-12-31$3.04 million-$0.01
2017-06-302017-09-30$1.91 million-$0.03
2017-03-312017-06-30$44.04 million-$0.06
2016-12-312017-03-31$7.61 million-$0.04
2016-09-302016-11-14$5.19 million$0.01
2016-06-302016-09-30$2.85 million-$0.05
2016-03-312016-06-30$5.37 million-$0.08
2015-12-312016-03-31$8.16 million-$0.08
2015-09-302015-12-31$4.39 million-$0.08
2015-06-302015-09-30$2.19 million$0.04
2015-03-312015-06-30$5.86 million-$0.10
2014-12-312015-03-31$8.97 million-$0.09
2014-09-302014-12-31$5.13 million-$0.04
2014-06-302014-09-30$1.8 million-$0.18
2014-03-312014-06-30$6.17 million-$0.19
2013-12-312014-03-31$9.6 million-$0.05
2013-09-302013-12-31$5.95 million$0.04
2013-06-302013-09-30$1.94 million$0.08
2013-03-312013-06-30$7.54 million-$0.11
2012-12-312013-03-31$9.08 million$0.02
2012-09-302012-12-31$5.42 million$0.03
2012-06-302012-09-30$1.89 million$0.07
2012-03-312012-06-30$6.02 million-$0.13
2011-12-312012-03-31$7.46 million-$0.05
2011-09-302011-12-31$5.08 million-$0.13
2011-06-302011-09-30$1.74 million$0.07
2011-03-312011-06-30$3.17 million-$0.07
2010-12-312011-03-31$6.19 million-$0.07
2010-09-302010-12-31$5.2 million-$0.08$0.09-188.22%
2010-06-302010-08-12$1.13 million-$0.15-$0.150%
2010-03-312010-05-18$1.98 million-$0.08
2009-12-312010-03-25$9.1 million$0.14-$0.011500%
2009-09-302009-11-12$4.98 million$0.09-$0.26134.62%
2009-06-302009-08-05$1.75 million-$0.36-$0.22-63.64%
2009-03-312009-05-01$3.99 million-$0.17-$0.10-70%
2008-12-312009-02-26$6.78 million-$0.15
2008-09-302008-10-30$6.36 million$0.07
2008-06-302008-07-31$2.07 million-$0.22
2008-03-312008-04-24$5.31 million-$0.12
2007-12-312008-03-03$10.74 million$0.12
2007-09-302007-10-25$9.13 million$0.10
2007-06-302007-07-26$2.22 million-$0.28
2007-03-312007-04-26$6.15 million-$0.15
2006-12-312007-02-27$14.2 million$0.09
2006-09-302006-10-26$11.48 million$0.08
2006-06-302006-07-27$6.18 million-$0.21
2006-03-312006-04-27$10.27 million-$0.12
2005-12-312006-02-23$17.74 million$0.16
2005-09-302005-11-14$15.32 million$0.23
2005-06-302005-07-28$8.84 million-$0.15
2005-03-312005-04-28$11.75 million-$0.01-$0.0785.71%
2004-12-312005-02-24$17.75 million$0.13$0.20-35%
2004-09-302004-10-28$9.69 million$0.03$0.0250%
2004-06-302004-07-30$6.9 million-$0.08-$0.03-166.67%
2004-03-312004-04-29$9.61 million-$0.07
2003-12-312004-02-26$16.39 million$0.17
2003-09-302003-10-28$9.33 million$0.01
2003-06-302003-07-24$7.19 million-$0.09
2003-03-312003-03-31$8.59 million-$0.09
2002-09-302002-09-30$8.55 million-$0.05
2002-06-302002-06-30$5.2 million-$0.13
2002-03-312002-03-31$5.4 million-$0.16
2001-12-312002-02-19$9.33 million$0.09$0.03200%
2001-09-302001-10-25$5.41 million$0.03$0.08-62.5%
2001-06-302001-07-26$4.66 million$0.06-$0.01700%
2001-03-312001-04-26$5.2 million-$0.04-$0.1163.64%
2000-12-312001-02-20$7.11 million$0.03$0.28-89.29%
2000-09-302000-10-26$3.47 million$0.01-$0.02150%
2000-06-302000-07-28$820000-$0.16-$0.06-166.67%
2000-03-312000-04-28$5.41 million-$0.38-$0.01-3700%
1999-12-312000-02-18-$0.12$0.13-192.31%
1999-09-301999-09-30$0.00
1999-06-301999-06-30-$0.10
1999-03-311999-03-31-$0.15
1998-09-301998-10-30$0.20$0.23-13.04%
1998-06-301998-07-31$0.00-$0.04100.25%
1998-03-311998-05-01$0.08$0.13-38.46%
1997-12-311998-02-23$0.60$0.5020%
1997-09-301997-11-12$0.27$0.1942.11%
1997-06-301997-08-13$0.07$0.08-12.5%

ProPhase Labs, Inc (PRPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ProPhase Labs, Inc (PRPH) Chart:

ProPhase Labs, Inc (PRPH) News:

Below you will find a list of latest news for ProPhase Labs, Inc (PRPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ProPhase Labs, Inc (PRPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.53.7CALL0 2321.45TRUE00
2024-05-1751.65CALL0 375.31TRUE00
2024-05-177.50.68CALL1 12481.22FALSE0.130.24
2024-05-17100CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.1PUT0 40103.85FALSE00
2024-05-177.50PUT0 0101.48TRUE00
2024-05-17103.5PUT60 60216.14TRUE0.70.25
2024-07-192.52.65CALL0 30188.32TRUE00
2024-07-1951.45CALL0 1067.33TRUE00
2024-07-197.50.75CALL10 6691.05FALSE-0.15-0.17
2024-07-19100.02CALL0 1290FALSE00
2024-07-192.50.2PUT0 10FALSE00
2024-07-1950.19PUT0 56141.64FALSE00
2024-07-197.52.22PUT0 671.13TRUE00
2024-07-19103.8PUT20 2073.33TRUE10.36
2024-10-182.52.5CALL0 10146.05TRUE00
2024-10-1851.7CALL0 760.27TRUE00
2024-10-187.50.85CALL0 7871.5FALSE00
2024-10-18100.49CALL1 076.67FALSE0.490
2024-10-182.50.15PUT0 10FALSE00
2024-10-1850.45PUT5 663.93FALSE0.450
2024-10-187.51.15PUT0 182.17TRUE00
2024-10-18100PUT0 074.21TRUE00

Latest PRPH Trades:

Date Shares Price
Jun 13, 2022 7:45 PM EST1$9.95
Jun 13, 2022 7:56 PM EST2000$9.855
Jun 13, 2022 7:56 PM EST100$9.87
Jun 13, 2022 7:57 PM EST2000$9.87
Jun 13, 2022 7:57 PM EST6$9.9

ProPhase Labs, Inc (PRPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220012453/0001493152-20-012453-index.htm
2018-07-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/868278/000000000018020460/0000000000-18-020460-index.htm
2017-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000114036117037087/0001140361-17-037087-index.htm
2017-10-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/868278/000114036117037109/0001140361-17-037109-index.htm
2018-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/868278/000114036118003941/0001140361-18-003941-index.htm
2019-12-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000138296319000156/0001382963-19-000156-index.htm
2017-08-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/868278/000149315217010103/0001493152-17-010103-index.htm
2017-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217010672/0001493152-17-010672-index.htm
2017-09-26SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/868278/000149315217010924/0001493152-17-010924-index.htm
2017-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217010926/0001493152-17-010926-index.htm
2017-09-29SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/868278/000149315217011067/0001493152-17-011067-index.htm
2017-09-298-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217011068/0001493152-17-011068-index.htm
2017-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217011101/0001493152-17-011101-index.htm
2017-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217011126/0001493152-17-011126-index.htm
2017-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217011127/0001493152-17-011127-index.htm
2017-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217011128/0001493152-17-011128-index.htm
2017-10-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/868278/000149315217011189/0001493152-17-011189-index.htm
2017-10-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217011295/0001493152-17-011295-index.htm
2017-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315217012867/0001493152-17-012867-index.htm
2017-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217012869/0001493152-17-012869-index.htm
2017-11-20SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/868278/000149315217013521/0001493152-17-013521-index.htm
2017-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217014721/0001493152-17-014721-index.htm
2017-12-19SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/868278/000149315217014795/0001493152-17-014795-index.htm
2017-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217014798/0001493152-17-014798-index.htm
2017-12-21SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/868278/000149315217014939/0001493152-17-014939-index.htm
2017-12-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315217014941/0001493152-17-014941-index.htm
2017-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315217015051/0001493152-17-015051-index.htm
2017-12-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/868278/000149315217015054/0001493152-17-015054-index.htm
2018-01-233/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218000883/0001493152-18-000883-index.htm
2018-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218002422/0001493152-18-002422-index.htm
2018-02-218-A12G/ARegistration of securities [Section 12(g)]https://www.sec.gov/Archives/edgar/data/868278/000149315218002425/0001493152-18-002425-index.htm
2018-02-2115-12GSecurities registration termination [Section 12(g)]https://www.sec.gov/Archives/edgar/data/868278/000149315218002426/0001493152-18-002426-index.htm
2018-02-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/868278/000149315218002595/0001493152-18-002595-index.htm
2018-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218002597/0001493152-18-002597-index.htm
2018-02-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/868278/000149315218002711/0001493152-18-002711-index.htm
2018-03-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218003750/0001493152-18-003750-index.htm
2018-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/868278/000149315218003776/0001493152-18-003776-index.htm
2018-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/868278/000149315218004041/0001493152-18-004041-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218005235/0001493152-18-005235-index.htm
2018-04-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/868278/000149315218005427/0001493152-18-005427-index.htm
2018-04-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/868278/000149315218005546/0001493152-18-005546-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218006377/0001493152-18-006377-index.htm
2018-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218006906/0001493152-18-006906-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218007006/0001493152-18-007006-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218007358/0001493152-18-007358-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218007766/0001493152-18-007766-index.htm
2018-06-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/868278/000149315218008330/0001493152-18-008330-index.htm
2018-06-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/868278/000149315218009178/0001493152-18-009178-index.htm
2018-07-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/868278/000149315218009597/0001493152-18-009597-index.htm
2018-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218010341/0001493152-18-010341-index.htm
2018-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218010342/0001493152-18-010342-index.htm
2018-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218011937/0001493152-18-011937-index.htm
2018-08-15NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/868278/000149315218011939/0001493152-18-011939-index.htm
2018-08-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218012354/0001493152-18-012354-index.htm
2018-08-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218012358/0001493152-18-012358-index.htm
2018-08-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218012360/0001493152-18-012360-index.htm
2018-08-2010-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/868278/000149315218012362/0001493152-18-012362-index.htm
2018-08-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218012364/0001493152-18-012364-index.htm
2018-08-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218012368/0001493152-18-012368-index.htm
2018-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218012403/0001493152-18-012403-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218014008/0001493152-18-014008-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218014009/0001493152-18-014009-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315218015980/0001493152-18-015980-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315218017621/0001493152-18-017621-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315218017964/0001493152-18-017964-index.htm
2019-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219000674/0001493152-19-000674-index.htm
2019-01-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219000748/0001493152-19-000748-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219003899/0001493152-19-003899-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/868278/000149315219003946/0001493152-19-003946-index.htm
2019-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219004917/0001493152-19-004917-index.htm
2019-04-19DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/868278/000149315219005646/0001493152-19-005646-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315219007096/0001493152-19-007096-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219007141/0001493152-19-007141-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219008241/0001493152-19-008241-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219008529/0001493152-19-008529-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219012034/0001493152-19-012034-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315219012065/0001493152-19-012065-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219012853/0001493152-19-012853-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219012854/0001493152-19-012854-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219015005/0001493152-19-015005-index.htm
2019-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219015007/0001493152-19-015007-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315219016884/0001493152-19-016884-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219016938/0001493152-19-016938-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219018118/0001493152-19-018118-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315219018255/0001493152-19-018255-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315219018354/0001493152-19-018354-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220000170/0001493152-20-000170-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220000171/0001493152-20-000171-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/868278/000149315220004807/0001493152-20-004807-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220004862/0001493152-20-004862-index.htm
2020-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220004961/0001493152-20-004961-index.htm
2020-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220004963/0001493152-20-004963-index.htm
2020-03-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/868278/000149315220005024/0001493152-20-005024-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220005723/0001493152-20-005723-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220005725/0001493152-20-005725-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/868278/000149315220006542/0001493152-20-006542-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315220008391/0001493152-20-008391-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220008574/0001493152-20-008574-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220009667/0001493152-20-009667-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220012442/0001493152-20-012442-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220012453/0001493152-20-012453-index.htm
2020-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220013210/0001493152-20-013210-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220015196/0001493152-20-015196-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/868278/000149315220015271/0001493152-20-015271-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220016097/0001493152-20-016097-index.htm
2020-08-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/868278/000149315220016098/0001493152-20-016098-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220016100/0001493152-20-016100-index.htm
2020-08-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220016204/0001493152-20-016204-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220016677/0001493152-20-016677-index.htm
2020-09-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220017637/0001493152-20-017637-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220017638/0001493152-20-017638-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220017639/0001493152-20-017639-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/868278/000149315220017640/0001493152-20-017640-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220017997/0001493152-20-017997-index.htm
2020-09-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/868278/000149315220018227/0001493152-20-018227-index.htm
2020-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220018228/0001493152-20-018228-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220018633/0001493152-20-018633-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220018968/0001493152-20-018968-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/868278/000149315220019947/0001493152-20-019947-index.htm
2018-07-05EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/868278/999999999518001713/9999999995-18-001713-index.htm

ProPhase Labs, Inc (PRPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ProPhase Labs, Inc (PRPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2422%
Institutional Ownership: 417%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-01LOUIS MD GLECKELDirectorBuy5,740.001.9611,250.40104,330.00https://www.sec.gov/Archives/edgar/data/868278/000149315219015007/0001493152-19-015007-index.htm
2020-01-01LOUIS MD GLECKELDirectorBuy5,564.002.0211,239.28109,894.00https://www.sec.gov/Archives/edgar/data/868278/000149315220000170/0001493152-20-000170-index.htm
2017-09-29ROBERT V JR CUDDIHYChief Financial OfficerSell358,621.002.30824,828.30132,703.00https://www.sec.gov/Archives/edgar/data/868278/000149315217011127/0001493152-17-011127-index.htm
2019-08-14Jason Michael BarrDirectorBuy6,000.002.0512,300.0013,721.00https://www.sec.gov/Archives/edgar/data/868278/000149315219012853/0001493152-19-012853-index.htm
2019-08-15Jason Michael BarrDirectorBuy2,500.002.055,125.0016,221.00https://www.sec.gov/Archives/edgar/data/868278/000149315219012853/0001493152-19-012853-index.htm
2019-10-01Jason Michael BarrDirectorBuy2,870.001.965,625.2019,091.00https://www.sec.gov/Archives/edgar/data/868278/000149315219015005/0001493152-19-015005-index.htm
2020-03-26LOUIS MD GLECKELDirectorBuy100,000.001.75175,000.00209,894.00https://www.sec.gov/Archives/edgar/data/868278/000149315220004963/0001493152-20-004963-index.htm
2020-04-01LOUIS MD GLECKELDirectorBuy6,068.001.8511,225.80215,962.00https://www.sec.gov/Archives/edgar/data/868278/000149315220005725/0001493152-20-005725-index.htm
2020-01-01Jason Michael BarrDirectorBuy2,782.002.025,619.6421,873.00https://www.sec.gov/Archives/edgar/data/868278/000149315220000171/0001493152-20-000171-index.htm
2020-07-01LOUIS MD GLECKELDirectorBuy7,878.001.4311,265.54223,840.00https://www.sec.gov/Archives/edgar/data/868278/000149315220012453/0001493152-20-012453-index.htm
2017-09-29Ted William KarkusCEO & CHAIRMANSell364,950.002.30839,385.002,309,638.00https://www.sec.gov/Archives/edgar/data/868278/000149315217011126/0001493152-17-011126-index.htm
2020-08-13Ted William KarkusCEO & CHAIRMANSell50,000.002.75137,500.002,419,528.00https://www.sec.gov/Archives/edgar/data/868278/000149315220016100/0001493152-20-016100-index.htm
2017-12-21Ted William KarkusCEO & CHAIRMANSell424,789.002.30977,014.702,484,849.00https://www.sec.gov/Archives/edgar/data/868278/000149315217015051/0001493152-17-015051-index.htm
2020-03-26Ted William KarkusCEO & CHAIRMANSell100,000.001.75175,000.002,549,528.00https://www.sec.gov/Archives/edgar/data/868278/000149315220004961/0001493152-20-004961-index.htm
2020-04-01Jason Michael BarrDirectorBuy3,641.001.856,735.8525,514.00https://www.sec.gov/Archives/edgar/data/868278/000149315220005723/0001493152-20-005723-index.htm
2018-05-15Ted William KarkusCEO & CHAIRMANBuy100,000.001.65165,000.002,584,849.00https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/0001493152-18-007358-index.htm
2018-05-15Ted William KarkusCEO & CHAIRMANBuy150,000.002.00300,000.002,704,574.00https://www.sec.gov/Archives/edgar/data/868278/000149315218007358/0001493152-18-007358-index.htm
2020-08-13LOUIS MD GLECKELDirectorBuy50,000.002.75137,500.00273,840.00https://www.sec.gov/Archives/edgar/data/868278/000149315220016097/0001493152-20-016097-index.htm
2017-12-14Ted William KarkusCEO & CHAIRMANBuy600,000.001.00600,000.002,909,638.00https://www.sec.gov/Archives/edgar/data/868278/000149315217014721/0001493152-17-014721-index.htm
2020-07-01Jason Michael BarrDirectorBuy4,727.001.436,759.6130,241.00https://www.sec.gov/Archives/edgar/data/868278/000149315220012442/0001493152-20-012442-index.htm
2018-07-19Mark A. BurnettDirectorBuy3,737.003.0111,248.37314,545.00https://www.sec.gov/Archives/edgar/data/868278/000149315218010341/0001493152-18-010341-index.htm
2018-10-01Mark A. BurnettDirectorBuy3,737.003.0111,248.37318,282.00https://www.sec.gov/Archives/edgar/data/868278/000149315218014008/0001493152-18-014008-index.htm
2017-09-14ROBERT V JR CUDDIHYChief Financial OfficerBuy200,000.001.00200,000.00331,324.00https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/0001493152-17-010672-index.htm
2017-09-14ROBERT V JR CUDDIHYChief Financial OfficerBuy120,000.001.65198,000.00451,324.00https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/0001493152-17-010672-index.htm
2017-09-14ROBERT V JR CUDDIHYChief Financial OfficerBuy40,000.001.3955,600.00491,324.00https://www.sec.gov/Archives/edgar/data/868278/000149315217010672/0001493152-17-010672-index.htm
2017-09-29Braden Michael Leonard10% Share HolderSell1,695,305.002.303,899,201.50627,322.00https://www.sec.gov/Archives/edgar/data/868278/000114036117037087/0001140361-17-037087-index.htm
2017-09-29Jason Michael BarrDirectorSell4,379.002.3010,071.707,721.00https://www.sec.gov/Archives/edgar/data/868278/000149315217011128/0001493152-17-011128-index.htm
2018-07-19LOUIS MD GLECKELDirectorBuy3,737.003.0111,248.3782,972.00https://www.sec.gov/Archives/edgar/data/868278/000149315218010342/0001493152-18-010342-index.htm
2018-10-01LOUIS MD GLECKELDirectorBuy3,737.003.0111,248.3786,709.00https://www.sec.gov/Archives/edgar/data/868278/000149315218014009/0001493152-18-014009-index.htm
2019-01-02LOUIS MD GLECKELDirectorBuy3,583.003.1411,250.6290,292.00https://www.sec.gov/Archives/edgar/data/868278/000149315219000674/0001493152-19-000674-index.htm
2019-04-03LOUIS MD GLECKELDirectorBuy3,571.003.1511,248.6593,863.00https://www.sec.gov/Archives/edgar/data/868278/000149315219004917/0001493152-19-004917-index.htm
2019-07-01LOUIS MD GLECKELDirectorBuy4,727.002.3811,250.2698,590.00https://www.sec.gov/Archives/edgar/data/868278/000149315219012854/0001493152-19-012854-index.htm